The levels of both lipid rafts and raft-located acetylcholinesterase dimers increase in muscle of mice with muscular dystrophy by merosin deficiency.

[1]  J. Jordán,et al.  Cholinesterase activity in brain of senescence‐accelerated‐resistant mouse SAMR1 and its variation in brain of senescence‐accelerated‐prone mouse SAMP8 , 2010, Journal of neuroscience research.

[2]  D. Larner,et al.  Muscular dystrophy begins early in embryonic development deriving from stem cell loss and disrupted skeletal muscle formation , 2009, Disease Models & Mechanisms.

[3]  J. Dennis,et al.  Lattices, rafts, and scaffolds: domain regulation of receptor signaling at the plasma membrane , 2009, The Journal of cell biology.

[4]  R. Choi,et al.  Transcriptional regulation of proline-rich membrane anchor (PRiMA) of globular form acetylcholinesterase in neuron: An inductive effect of neuron differentiation , 2009, Brain Research.

[5]  S. Moore,et al.  Non‐enzymatic developmental functions of acetylcholinesterase – the question of redundancy , 2008, The FEBS journal.

[6]  D. Liang,et al.  Old and new questions about cholinesterases. , 2008, Chemico-biological interactions.

[7]  F. Campoy,et al.  Targeting of acetylcholinesterase to lipid rafts of muscle. , 2008, Chemico-biological interactions.

[8]  Hermona Soreq,et al.  N-Acetylcholinesterase-Induced Apoptosis in Alzheimer's Disease , 2008, PloS one.

[9]  S. Moore,et al.  Interaction of acetylcholinesterase with the G4 domain of the laminin alpha1-chain. , 2008, The Biochemical journal.

[10]  Y. Yoo,et al.  Interactions of acetylcholinesterase with caveolin-1 and subsequently with cytochrome c are required for apoptosome formation. , 2008, Carcinogenesis.

[11]  P. Layer,et al.  Acetylcholinesterase in cell adhesion, neurite growth and network formation , 2008, The FEBS journal.

[12]  J. Hancock,et al.  Lipid rafts and membrane traffic , 2007, FEBS letters.

[13]  Nina L. Siow,et al.  Regulation of a Transcript Encoding the Proline-rich Membrane Anchor of Globular Muscle Acetylcholinesterase , 2007, Journal of Biological Chemistry.

[14]  R. Cohn,et al.  Congenital muscular dystrophies: new aspects of an expanding group of disorders. , 2007, Biochimica et biophysica acta.

[15]  Mark M. Rasenick,et al.  Lipid raft microdomains and neurotransmitter signalling , 2007, Nature Reviews Neuroscience.

[16]  N. Hooper,et al.  Sphingomyelin chain length influences the distribution of GPI-anchored proteins in rafts in supported lipid bilayers , 2007, Molecular membrane biology.

[17]  K. Monastyrskaya,et al.  Phenotypic conversion leads to structural and functional changes of smooth muscle sarcolemma. , 2006, Experimental cell research.

[18]  K. Gaus,et al.  Agrin elicits membrane lipid condensation at sites of acetylcholine receptor clusters in C2C12 myotubes Published, JLR Papers in Press, July 1, 2006. , 2006, Journal of Lipid Research.

[19]  H. Hoppeler,et al.  Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia , 2006, The Journal of pathology.

[20]  D. Allen,et al.  MUSCLE DAMAGE IN MDX (DYSTROPHIC) MICE: ROLE OF CALCIUM AND REACTIVE OXYGEN SPECIES , 2006, Clinical and experimental pharmacology & physiology.

[21]  L. Mei,et al.  Lipid Rafts Serve as a Signaling Platform for Nicotinic Acetylcholine Receptor Clustering , 2006, The Journal of Neuroscience.

[22]  H. Soreq,et al.  Virtues and woes of AChE alternative splicing in stress-related neuropathologies , 2006, Trends in Neurosciences.

[23]  Leia M. Smith,et al.  Lipid rafts remodeling in estrogen receptor–negative breast cancer is reversed by histone deacetylase inhibitor , 2006, Molecular Cancer Therapeutics.

[24]  Z. Yablonka-Reuveni,et al.  Satellite cells from dystrophic (Mdx) mice display accelerated differentiation in primary cultures and in isolated myofibers , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.

[25]  F. Campoy,et al.  The increased ecto-5'-nucleotidase activity in muscle, heart and liver of laminin alpha2-deficient mice is not caused by an elevation in the mRNA content. , 2006, The international journal of biochemistry & cell biology.

[26]  Carlos A. Ruiz,et al.  Targeting acetylcholinesterase to the neuromuscular synapse. , 2005, Chemico-biological interactions.

[27]  C. Legay,et al.  Acetylcholinesterase and molecular interactions at the neuromuscular junction. , 2005, Chemico-biological interactions.

[28]  F. Campoy,et al.  Muscular dystrophy by merosin deficiency decreases acetylcholinesterase activity in thymus of Lama2dy mice , 2005, Journal of neurochemistry.

[29]  R. O. Godinho,et al.  Developing skeletal muscle cells express functional muscarinic acetylcholine receptors coupled to different intracellular signaling systems , 2005, British journal of pharmacology.

[30]  R. Parton,et al.  Cholesterol and fatty acids regulate dynamic caveolin trafficking through the Golgi complex and between the cell surface and lipid bodies. , 2005, Molecular biology of the cell.

[31]  S. Fawzi-Grancher,et al.  Role of Ca2+ in the effects of shear stress and TNF-alpha on caveolin-1 expression. , 2005, Clinical hemorheology and microcirculation.

[32]  Susan C. Brown,et al.  Congenital muscular dystrophy: molecular and cellular aspects , 2005, Cellular and Molecular Life Sciences CMLS.

[33]  F. Tronche,et al.  Combinatorial Complexity of 5′ Alternative Acetylcholinesterase Transcripts and Protein Products*[boxs] , 2004, Journal of Biological Chemistry.

[34]  C. Rao,et al.  Overexpression of caveolin-1 in experimental colon adenocarcinomas and human colon cancer cell lines. , 2004, Oncology reports.

[35]  F. Campoy,et al.  Breast Cancer Metastasis Alters Acetylcholinesterase Activity and the Composition of Enzyme Forms in Axillary Lymph Nodes , 2003, Breast Cancer Research and Treatment.

[36]  M. Lisanti,et al.  The biology of caveolae: lessons from caveolin knockout mice and implications for human disease. , 2003, Molecular interventions.

[37]  F. Burkhard,et al.  Membrane segregation and downregulation of raft markers during sarcolemmal differentiation in skeletal muscle cells. , 2003, Developmental biology.

[38]  F. Campoy,et al.  Muscular dystrophy with laminin deficiency decreases the content of butyrylcholinesterase tetramers in sciatic nerves of Lama2dy mice , 2002, Neuroscience Letters.

[39]  F. Campoy,et al.  Identification of inactive ecto‐5′‐nucleotidase in normal mouse muscle and its increased activity in dystrophic Lama2dy mice , 2001, Journal of neuroscience research.

[40]  J. Engelman,et al.  Caveolin-3 Null Mice Show a Loss of Caveolae, Changes in the Microdomain Distribution of the Dystrophin-Glycoprotein Complex, and T-tubule Abnormalities* , 2001, The Journal of Biological Chemistry.

[41]  K. Oexle,et al.  Cause of progression in Duchenne muscular dystrophy: impaired differentiation more probable than replicative aging. , 2001, Neuropediatrics.

[42]  F. Ciruela,et al.  Involvement of caveolin in ligand-induced recruitment and internalization of A(1) adenosine receptor and adenosine deaminase in an epithelial cell line. , 2001, Molecular pharmacology.

[43]  R. Prohaska,et al.  Stomatin, flotillin-1, and flotillin-2 are major integral proteins of erythrocyte lipid rafts. , 2001, Blood.

[44]  S. Brimijoin,et al.  Abundant Tissue Butyrylcholinesterase and Its Possible Function in the Acetylcholinesterase Knockout Mouse , 2000, Journal of neurochemistry.

[45]  S. Fine,et al.  Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[46]  F. Campoy,et al.  The ecto-5'-nucleotidase subunits in dimers are not linked by disulfide bridges but by non-covalent bonds. , 2000, Biochimica et biophysica acta.

[47]  F. Sotgia,et al.  Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy. , 1999, Biochemical and biophysical research communications.

[48]  Wenrong Wu,et al.  Increased caveolin‐3 levels in mdx mouse muscles , 1998, FEBS letters.

[49]  F. Campoy,et al.  Glycosylation of Acetylcholinesterase Forms in Microsomal Membranes from Normal and Dystrophic Lama2dy Mouse Muscle , 1997, Journal of neurochemistry.

[50]  P. Oh,et al.  Organized Endothelial Cell Surface Signal Transduction in Caveolae Distinct from Glycosylphosphatidylinositol-anchored Protein Microdomains* , 1997, The Journal of Biological Chemistry.

[51]  C. J. Vidal,et al.  Molecular forms of acetyl‐ and butyrylcholinesterase in normal and dystrophic mouse brain , 1996, Journal of neuroscience research.

[52]  J. Changeux,et al.  Developmental Regulation of Acetylcholinesterase Transcripts in the Mouse Diaphragm: Alternative Splicing and Focalization , 1995, The European journal of neuroscience.

[53]  V. Gisiger,et al.  Localization of the pool of G4 acetylcholinesterase characterizing fast muscles and its alteration in murine muscular dystrophy , 1988, Journal of neuroscience research.

[54]  K. Fischbeck,et al.  Freeze‐fracture analysis of plasma membrane cholesterol in duchenne muscle , 1983, Annals of neurology.

[55]  P. Vigneron,et al.  Acetylcholinesterase forms in fast and slow rabbit muscle , 1982, Nature.